Clinical trials
Completed Multiple Myeloma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 1 |
| 2014 | 10 |
| 2015 | 7 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 80 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 10 |
| Amgen | 9 |
| Janssen Research & Development, LLC | 9 |
| Celgene | 7 |
| Peter MacCallum Cancer Centre, Australia | 6 |
| Bristol-Myers Squibb | 5 |
| GlaxoSmithKline | 5 |
| Sanofi | 4 |
| AbbVie | 3 |
| Genentech, Inc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 80 |
| Recurrence | 16 |
| Neoplasms, Plasma Cell | 9 |
| Lymphoma | 7 |
| Hematologic Neoplasms | 3 |
| Leukemia | 3 |
| Neoplasms | 3 |
| Bone Neoplasms | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, T-Cell, Cutaneous | 2 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.